UCB PHARMA PATENTS FACING OPPOSITIONS
Top patents of UCB PHARMA facing oppositions at the European Patent Office (EPO)
| Patent Number | Grant Date | Patent Title | Expected Expiration Date | Facing Oppositions | Activity Alert |
|---|---|---|---|---|---|
| EP2869844B2 | 21 Jun, 2023 | Treatment For Bone Diseases | NA | 1 | |
| EP2645997B1 | 10 Aug, 2022 | Once Daily Formulation Of Lacosamide | Dec, 2031 | 1 | |
| EP2345668B1 | 22 Sep, 2021 | Sclerostin Epitopes | Apr, 2026 | 1 | |
| EP3670528B1 | 08 Sep, 2021 | Sclerostin Binding Agents | NA | 1 | |
| EP2992891B1 | 05 Aug, 2020 | Pharmaceutical Composition Comprising Brivaracetam And Lacosamide With Synergistic Anticonvulsant Effect | Jun, 2027 | 1 | |
| EP2037965B1 | 30 Aug, 2017 | Pharmaceutical Composition With Synergistic Anticonvulsant Effect | Jun, 2027 | 1 |